Role of Biochemical Mediators in Clinical Nutrition and Surgical Metabolism
- 1 March 1988
- journal article
- review article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 12 (2), 212-218
- https://doi.org/10.1177/0148607188012002212
Abstract
Over the past several decades, research on the role of mediators in inflammation, immunity, repair processes, cell growth, and substrate metabolism have centered around the use of purified products of stimulated macrophages. With the current availability of recombinant mediators, the participation of individual monokines in cellular metabolism has been more clearly defined. Interactions among various mediators have been demonstrated, but their exact role in metabolism is currently under intense study. With the use of recombinant monokines, formal evidence for their participation in the acute phase response has been developed. Their use has also assisted in the reinterpretation of data gathered in older studies using purified preparations, which were almost certainly contaminated with several monokines. In this review we will try to give the reader insight into recent advances in the understanding of the role of cellular mediators in relation to nutrition and intermediary metabolism. With a clearer knowledge of the role of cellular mediators in the pathophysiology of disease, it may be possible to develop rationales for their therapeutic use as modulators of substrate metabolism during critical illness. (Journal of Parenteral and Enteral Nutrition 12: 212-218, 1988)Keywords
This publication has 40 references indexed in Scilit:
- Changes in energy expenditure and fat metabolism in rats infused with interleukin‐1European Journal of Clinical Investigation, 1987
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Secretory products of macrophages.Journal of Clinical Investigation, 1987
- Decreased serum interleukin 1 activity and monocyte interleukin 1 production in patients with fatal sepsisCritical Care Medicine, 1986
- Effect of Indomethacin on Proteolysis in Septic MuscleAnnals of Surgery, 1985
- Interleukin-1 and the Pathogenesis of the Acute-Phase ResponseNew England Journal of Medicine, 1984
- Interleukin-1Clinical Infectious Diseases, 1984
- Stimulation of Muscle Protein Degradation and Prostaglandin E2Release by Leukocytic Pyrogen (Interleukin-1)New England Journal of Medicine, 1983
- Muscle Proteolysis Induced by a Circulating Peptide in Patients with Sepsis or TraumaNew England Journal of Medicine, 1983